Phone: (919) 286-0411 x6093
Neurobiology Research Lab
Rm. 24, Bldg. 16, 508 Fulton St.
Durham , NC 27705
Email: shawn DOT acheson AT duke DOT edu
Psychiatry & Behavioral Sciences, School of Medicine
We currently study novel pharmacotherapies for the treatment of and recovery from Traumatic Brain Injury (TBI) using both behavioral and molecular end points. In addition, our group works closely with Dr. Scott Swartzwelder and his group to study the neurodevelopmental effects of drugs of abuse including alcohol and marijuana.
Postdoctoral Fellow, Department of Psychiatry and Behavioral Sciences, Behavioral Neuroscience & Clinical Neuropsychology, 1996-1998
Ph.D., Southern Illinois University, Psychology, Clinical-Experimental Psychology Program, 1997
Clinical Internship, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 1995-1996
M.A., Western Carolina University, Clinical Psychology, 1992
B.A., North Carolina State University, Psychology, 1988
Acheson, S.K., Moore, N.L.T., Kuhn, C.M., Wilson, W.A., & Swartzwelder, H.S. (2011). The Synthetic Cannabinoid WIN 55212-2 Differentially Modulates Thigmotaxsis but not Spatial Learning in Adolescent and Adult Animals. Neuroscience Letters, 487, 411-414.
Fleming, R., Acheson, S.K., Moore, S.D., Wilson, W.A., & Swartzwelder, H.S. (2011). GABA Transport Modulates the Ethanol Sensitivity of Tonic Inhibition in the Rat Dentate Gyrus. Alcohol, 45, 577-583.
Fleming, R.L., Acheson, S.K., Moore, S.D., Wilson, W.A., & Swartzwelder, H.S. (2012). In the Rat, Chronic Intermittent Ethanol Exposure During Adolescence Alters the Ethanol Sensitivity of Tonic Inhibition in Adulthood. Alcoholism: Clinical and Experimental Research, 36, 279-285.
Copyright 2008-2014 DIBS and Duke University. All rights reserved.